IT8667408A0 - Preparati farmaceutici ad effetto antiipertensivo e cardioprotettivo - Google Patents

Preparati farmaceutici ad effetto antiipertensivo e cardioprotettivo

Info

Publication number
IT8667408A0
IT8667408A0 IT8667408A IT6740886A IT8667408A0 IT 8667408 A0 IT8667408 A0 IT 8667408A0 IT 8667408 A IT8667408 A IT 8667408A IT 6740886 A IT6740886 A IT 6740886A IT 8667408 A0 IT8667408 A0 IT 8667408A0
Authority
IT
Italy
Prior art keywords
antihypertensive
pharmaceutical preparations
cardioprotective effect
cardioprotective
effect
Prior art date
Application number
IT8667408A
Other languages
English (en)
Other versions
IT1215172B (it
Inventor
Klaus Lobnitzer Kar Giebenhain
Karl Dieter Volger
Gerhard Zeib
Original Assignee
Roehm Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roehm Pharma Gmbh filed Critical Roehm Pharma Gmbh
Publication of IT8667408A0 publication Critical patent/IT8667408A0/it
Application granted granted Critical
Publication of IT1215172B publication Critical patent/IT1215172B/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Obesity (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
IT8667408A 1985-05-17 1986-05-16 Preparati farmaceutici ad effetto antiipertensivo e cardioprotettivo IT1215172B (it)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19853517820 DE3517820A1 (de) 1985-05-17 1985-05-17 Pharmazeutische praeparate mit antihypertensiver und kardioprotektiver wirkung

Publications (2)

Publication Number Publication Date
IT8667408A0 true IT8667408A0 (it) 1986-05-16
IT1215172B IT1215172B (it) 1990-01-31

Family

ID=6271008

Family Applications (1)

Application Number Title Priority Date Filing Date
IT8667408A IT1215172B (it) 1985-05-17 1986-05-16 Preparati farmaceutici ad effetto antiipertensivo e cardioprotettivo

Country Status (12)

Country Link
US (1) US5047235A (it)
EP (1) EP0205865B1 (it)
JP (1) JPH0678233B2 (it)
AT (1) ATE44129T1 (it)
AU (1) AU577947B2 (it)
CA (1) CA1277916C (it)
DE (1) DE3517820A1 (it)
FR (1) FR2581873B1 (it)
GB (1) GB2175206B (it)
IL (1) IL78794A (it)
IT (1) IT1215172B (it)
ZA (1) ZA863653B (it)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3739779A1 (de) * 1987-11-24 1989-06-08 Beiersdorf Ag Pharmazeutische praeparate
DE3908232C2 (de) * 1989-03-14 1998-02-26 Roehm Pharma Gmbh Verwendung von Verapamil zur Behandlung der Schlaf-Apnoe
US5886012A (en) * 1989-03-22 1999-03-23 Peter K. T. Pang Method of treatment for disease associated with excessive PHF using combination therapy involving exogenous calcium and calcium channel blockers
US5350771A (en) * 1989-03-22 1994-09-27 Peter K. T. Pang Method and treatment for hypertension using combination therapy involving exogenous calcium and calcium channel blockers
HUT70033A (en) * 1989-03-22 1995-09-28 Pang Process for producing synergetic pharmaceutical composition containing calcium channel blocking agent and calcium compound or vitamin d
CN1049115C (zh) * 1993-01-01 2000-02-09 上海医科大学 防御心肺脑低氧损害的复方制剂
US6083532A (en) * 1995-03-01 2000-07-04 Duramed Pharmaceuticals, Inc. Sustained release formulation containing three different types of polymers and tablet formed therefrom
US5695781A (en) * 1995-03-01 1997-12-09 Hallmark Pharmaceuticals, Inc. Sustained release formulation containing three different types of polymers
AR047880A1 (es) * 2004-02-17 2006-03-01 Novartis Ag COMBINACIoN DE UN INHIBIDOR DE RENINA Y DIURÉTICOS
US8784904B2 (en) * 2008-04-10 2014-07-22 U.S. Nutraceuticals, LLC Plant derived seed extract rich in essential fatty acids derived from perilla seed: composition of matter, manufacturing process and use
US8586104B2 (en) * 2008-04-10 2013-11-19 U.S. Nutraceuticals, LLC Plant derived seed extract rich in essentially fatty acids derived from Salvia hispanica L. seed: composition of matter, manufacturing process and use

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2658500C2 (de) * 1976-12-23 1986-10-09 Knoll Ag, 6700 Ludwigshafen Pharmazeutische Präparate mit kardioprotektiver Wirkung
US4444769A (en) * 1982-07-27 1984-04-24 Mylan Pharmaceuticals, Inc. Antihypertensive diuretic combination composition and associated method
US4526777A (en) * 1983-01-06 1985-07-02 Mylan Pharmaceuticals Inc. Pharmaceutical combination composition and associated method

Also Published As

Publication number Publication date
IT1215172B (it) 1990-01-31
FR2581873B1 (fr) 1993-01-15
AU5754686A (en) 1986-11-20
JPS61268624A (ja) 1986-11-28
JPH0678233B2 (ja) 1994-10-05
GB2175206A (en) 1986-11-26
IL78794A (en) 1991-03-10
AU577947B2 (en) 1988-10-06
ZA863653B (en) 1987-01-28
EP0205865A1 (de) 1986-12-30
GB8611946D0 (en) 1986-06-25
DE3517820C2 (it) 1992-07-30
CA1277916C (en) 1990-12-18
EP0205865B1 (de) 1989-06-21
FR2581873A1 (fr) 1986-11-21
GB2175206B (en) 1989-01-11
DE3517820A1 (de) 1986-11-20
US5047235A (en) 1991-09-10
ATE44129T1 (de) 1989-07-15

Similar Documents

Publication Publication Date Title
DK361786A (da) Granulaere farmaceutiske praeparater med forskudt afgivelse
IT8467767A0 (it) Preparati farmaceutici ad attivita antimicrobica e procedimento per laloro preparazione
DK30886D0 (da) Peptidderivater
DK164851C (da) N-phenylmethylenalkadienamider med analgetisk virkning samt farmaceutiske praeparater indeholdende samme
DK164852C (da) N-phenylmethylenalkanamider med analgetisk virkning samt farmaceutiske praeparater indeholdende samme
DK184087D0 (da) Farmaceutiske praeparater med forbedret biotilgaengelighed
DK259186A (da) Nasale farmaceutiske praeparater
IT8667408A0 (it) Preparati farmaceutici ad effetto antiipertensivo e cardioprotettivo
IT1197061B (it) Composizioni farmaceutiche ad azione vasodilatatrice e antianossica
DK369186D0 (da) Antivirus- og antitumorpraeparat
DK133786D0 (da) Praeparater
DK205986D0 (da) Proteinhydrolysat samt fremstilling deraf
NO873427L (no) Hudpleiepreparater med keratolytisk og antiinflammatorisk virkning.
DK527487D0 (da) Farmaceutiske praeparater med forlaenget afgivelse
MA20660A1 (fr) Derives de nitrofuranne, leur preparation et leur application
DK24986A (da) Allergenholdige praeparater
IT1229176B (it) Antibiotici antitumorali bbm-1675c e d
FR2591600B1 (fr) Derives de la glucosylmoranoline et leur preparation
IT1200603B (it) Composizione farmaceutiche ad attivita dopaminergica
DK402585A (da) Pseudooligosaccharider med alfa-glucosidase-inhiberende virkning, deres fremstilling og anvendelse samt farmaceutiske praeparater
IT1200467B (it) Formulazione farmaceutica
IT1185513B (it) Procedimento per l'ottenimento di preparati farmaceutici con effetto ritardato
IT8421431A1 (it) "nuovi preparati farmaceutici con azione antitumorale"
DK499986A (da) Farmaceutisk praeparat med antibakteriel virkning
DK156771C (da) Bis-dioxopiperazin-derivater med antitumor-aktivitet og laegemiddelformuleringer indeholdende saadanne forbindelser

Legal Events

Date Code Title Description
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19970530